465 related articles for article (PubMed ID: 12286473)
1. RU 486: an overview of mifepristone and its potential applications.
Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
[TBL] [Abstract][Full Text] [Related]
2. Antiprogestogens: from abortion to contraception.
Prog Hum Reprod Res; 1992; (22):6-7. PubMed ID: 12286013
[TBL] [Abstract][Full Text] [Related]
3. Life after Roe v. Wade.
Bauerlein M
Utne Read; 1992; ():17-20. PubMed ID: 12343822
[TBL] [Abstract][Full Text] [Related]
4. [A new antiprogestational compound, mifepristone (RU-486)].
Parisi C; Steffe M
Patol Clin Ostet Ginecol; 1988; 16(4):291-4. PubMed ID: 12345008
[TBL] [Abstract][Full Text] [Related]
5. RU 486 research forges on, despite political hurdles.
Watanabe ME
Scientist; 1994 Jan; 8(2):14-5. PubMed ID: 12288152
[TBL] [Abstract][Full Text] [Related]
6. Post-coital contraception.
Haspels AA
IPPF Med Bull; 1988 Oct; 22(5):1-3. PubMed ID: 12281624
[TBL] [Abstract][Full Text] [Related]
7. Uses of RU 486: a clinical update.
Elia D
IPPF Med Bull; 1986 Oct; 20(5):1-2. PubMed ID: 12341333
[TBL] [Abstract][Full Text] [Related]
8. [Population Council responsible for RU486 clinical trials in USA].
Aguillaume CJ
Ref Gynecol Obstet; 1993 Apr; 1(4):392. PubMed ID: 12288154
[TBL] [Abstract][Full Text] [Related]
9. Abortion. Is RU 486/PG in its current form likely to be appropriate for women in Bangladesh?
Kabir S; Germain A
Newsl Womens Glob Netw Reprod Rights; 1992; (38):39-45. PubMed ID: 12285435
[TBL] [Abstract][Full Text] [Related]
10. [The role of the progesterone antagonist, RU 486 (mifepristone), in preoperative cervical dilatation during the luteal phase. A randomized double-blind study].
Fernandez H; Durlot F; Dubois C; Ulmann A; Frydman R
Contracept Fertil Sex (Paris); 1990 Jan; 18(1):41-3. PubMed ID: 12283016
[TBL] [Abstract][Full Text] [Related]
11. The clinical use of RU 486 (Mefipristone).
Herrmann W
Res Reprod; 1989 Oct; 21(4):3. PubMed ID: 12282921
[TBL] [Abstract][Full Text] [Related]
12. Antiprogesterones.
Norman J
Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone: a potential contraceptive.
Heikinheimo O; Archer DF
Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone (RU 486) in the United States. What does the future hold?
Rosenfield A
N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive technologies: how much choice do we really have?
Fishel J
ZPG Report; 1997; 29(2):4-6. PubMed ID: 12293118
[TBL] [Abstract][Full Text] [Related]
16. News in contraception.
Contracept Rep; 1994 Jul; 5(3):14. PubMed ID: 12287814
[TBL] [Abstract][Full Text] [Related]
17. Fertility awareness affects method use.
Barnett B
Netw Res Triangle Park N C; 1996; 17(1):9. PubMed ID: 12320448
[TBL] [Abstract][Full Text] [Related]
18. RU-486 and the politics of reproduction.
Rosenfield A
Female Patient; 1989 Mar; 14(3):69, 73-4. PubMed ID: 12342816
[TBL] [Abstract][Full Text] [Related]
19. Contraception after unprotected sex.
Blaney CL
Netw Res Triangle Park N C; 1994 Dec; 15(2):4-8. PubMed ID: 12319047
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
